What is the difference between Liraglutide and Tirzepatide?

Liraglutide (Liraglutide (Saxenda / Victoza)) is graded A+ and is FDA-approved for weight management (Saxenda) and type 2 diabetes (Victoza). Tirzepatide (Tirzepatide (Mounjaro / Zepbound)) is graded A+ and is FDA-approved for weight management and type 2 diabetes. They are commonly compared because they share the categories: weight-loss, metabolic.

Which has stronger clinical evidence — Liraglutide or Tirzepatide?

On our internal evidence scale, Liraglutide is A+ and Tirzepatide is A+. A+ indicates large RCTs plus FDA approval; C indicates primarily preclinical or anecdotal evidence.

What is the typical dose of Liraglutide vs Tirzepatide?

Liraglutide: 0.6–3.0 mg daily (subcutaneous). Tirzepatide: 2.5–15 mg weekly (subcutaneous injection). Always work with a licensed clinician — peptide dosing should be individualized.

Liraglutide vs Tirzepatide

Both Liraglutide and Tirzepatide are used for weight-loss and metabolic. Here's how their evidence, dosing, and regulatory status actually compare.

Liraglutide

Evidence A+

Liraglutide (Saxenda / Victoza)

The original once-daily GLP-1 receptor agonist. Lower weight-loss magnitude than semaglutide but a longer real-world track record across diabetes and obesity.

View full Liraglutide profile →

Tirzepatide

Evidence A+

Tirzepatide (Mounjaro / Zepbound)

A dual GIP/GLP-1 receptor agonist that achieved up to 22.5% mean weight loss in the SURMOUNT-1 trial — the highest of any FDA-approved weight loss medication.

View full Tirzepatide profile →

Side-by-Side

Attribute	Liraglutide	Tirzepatide
Evidence Grade	A+	A+
FDA Status	FDA-approved for weight management (Saxenda) and type 2 diabetes (Victoza)	FDA-approved for weight management and type 2 diabetes
Typical Dose	0.6–3.0 mg daily (subcutaneous)	2.5–15 mg weekly (subcutaneous injection)
Clinics Indexed	540	1,850
Categories	weight-loss, metabolic	weight-loss, metabolic

Key reported benefits — Liraglutide

✓Weight loss
✓Appetite suppression
✓Glycemic control

Key reported benefits — Tirzepatide

✓Superior weight loss
✓Dual hormone targeting
✓Blood sugar control
✓Reduced cardiovascular risk

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons